GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 22 filers reported holding GAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $489,355 | -21.3% | 151,476 | +9.2% | 0.00% | – |
| Q2 2023 | $621,470 | +36.9% | 138,721 | +47.3% | 0.00% | – |
| Q1 2023 | $454,077 | +160920.2% | 94,207 | +4.5% | 0.00% | – |
| Q4 2022 | $282 | -99.9% | 90,114 | +2.4% | 0.00% | – |
| Q3 2022 | $286,000 | +210.9% | 87,967 | +240.7% | 0.00% | – |
| Q2 2022 | $92,000 | -11.5% | 25,818 | +0.7% | 0.00% | – |
| Q1 2022 | $104,000 | -2.8% | 25,628 | +27.8% | 0.00% | – |
| Q4 2021 | $107,000 | – | 20,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 30,293 | $303,000 | 0.42% |
| Greenlight Capital | 546,560 | $5,466,000 | 0.34% |
| CM Management, LLC | 10,000 | $100,000 | 0.07% |
| Granite Point Capital Management, L.P. | 155,709 | $1,559,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $581,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $501,000 | 0.01% |
| Banque Cantonale Vaudoise | 3,000 | $30,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 23,878 | $239,000 | 0.00% |
| MORGAN STANLEY | 800 | $8,000 | 0.00% |
| BlackRock Inc. | 11,659 | $116,000 | 0.00% |